these 3-oxo-4-azasteroids have a similar rank order of potency as inhibitors of 5 alpha-reductase in human normal , benign hyperplastic , and cancerous prostates , indicating that the inhibitor-binding sites of 5 alpha-reductase in the prostate in different pathological states are similar .
C2756987
inhibitors
C1318898
inhibitor